| 摘要 |
Phospholipase A2 inhibition the present invention relates to a method for treating or preventing a phospholipase A2 mediated condition (PMC) in a mammal suffering from or susceptible to such a condition. The method involves administering to such a mammal an amount effective to treat the condition of a compound selected from a certain group of butyrophenones.
|
